SAN FRANCISCO--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies today announced the completion of its third quarter audit. Additionally, the Company is providing a recap of its recent investor conference call, which was held on January 12th.
